Mineral Sunscreen Recalled for Current Good Manufacturing Practice Deviations
KABANA SKIN CARE is recalling In Your Face Mineral Tint SPF 31 sunscreen due to Current Good Manufacturing Practice (cGMP) deviations. The voluntary recall affects 76 bottles distributed in New Jersey, Florida, and Michigan.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II drug recall initiated voluntarily by the firm due to manufacturing practice deviations. No illnesses, injuries, or adverse events are reported. The recall is classified as a precautionary quality-related matter without identified health hazards.
Plain-English summary
KABANA SKIN CARE is recalling In Your Face Mineral Tint SPF 31, a zinc oxide-based mineral sunscreen with SPF 31, manufactured for IN YOUR FACE Skin Care in Belleair Bluffs, Florida. The product is sold in 50 mL (1.7 fl oz) bottles under NDC 73369-1601-1. The recall affects lot 408-002.
The recall was initiated due to Current Good Manufacturing Practice (cGMP) deviations. KABANA SKIN CARE voluntarily initiated this recall on March 12, 2025, and it was classified by the FDA on July 10, 2025. A total of 76 bottles are affected.
The recalled product was distributed in New Jersey, Florida, and Michigan. Consumers who have purchased this sunscreen should stop using it and contact KABANA SKIN CARE or the FDA for instructions on return or disposal of the product.
The recalled product
- Product
- In Your Face Mineral Tint SPF 31, Zinc Oxide 25%, Tinted Sunscreen Broad Spectrum UVA & UVB chemical free, Organic Ingredients, Biodegradable & Baby Safe, 50 mL - 1.7 fl oz per bottle, Manufactured for IN YOUR FACE Skin Care, Belleair Bluffs, FL, Made in USA, NDC: 73369-1601-1
- Manufacturer
- KABANA SKIN CARE
- Category
- Drug — Topical Sunscreen
- Hazard
- manufacturing-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 408-002
Distribution
Distributed in 3 states:
- FL
- MI
- NJ
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27